230 related articles for article (PubMed ID: 15161669)
1. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database.
Goldin LR; Pfeiffer RM; Li X; Hemminki K
Blood; 2004 Sep; 104(6):1850-4. PubMed ID: 15161669
[TBL] [Abstract][Full Text] [Related]
2. Familial B-cell chronic lymphocytic leukemia in a population of patients from Southern Italy.
Capalbo S; Callea V; Musolino C; Guglielmo P; D'Arena G; Fragasso A; Battista C; Giustolisi R; Brugiatelli M; Liso V
Int J Hematol; 2004 May; 79(4):354-7. PubMed ID: 15218964
[TBL] [Abstract][Full Text] [Related]
3. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
[TBL] [Abstract][Full Text] [Related]
4. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.
Goldin LR; Björkholm M; Kristinsson SY; Turesson I; Landgren O
Haematologica; 2009 May; 94(5):647-53. PubMed ID: 19286886
[TBL] [Abstract][Full Text] [Related]
5. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
Kristinsson SY; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
Blood; 2008 Oct; 112(8):3052-6. PubMed ID: 18703425
[TBL] [Abstract][Full Text] [Related]
6. Familial aggregation of Hodgkin lymphoma and related tumors.
Goldin LR; Pfeiffer RM; Gridley G; Gail MH; Li X; Mellemkjaer L; Olsen JH; Hemminki K; Linet MS
Cancer; 2004 May; 100(9):1902-8. PubMed ID: 15112271
[TBL] [Abstract][Full Text] [Related]
7. Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples.
Goldin LR; Landgren O; McMaster ML; Gridley G; Hemminki K; Li X; Mellemkjaer L; Olsen JH; Linet MS
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2402-6. PubMed ID: 16214923
[TBL] [Abstract][Full Text] [Related]
8. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database.
Altieri A; Bermejo JL; Hemminki K
Blood; 2005 Jul; 106(2):668-72. PubMed ID: 15811955
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of lymphoproliferative disorders in relatives of patients with B-cell chronic lymphocytic leukemia: relevance of the degree of familial linkage.
Capalbo S; Trerotoli P; Ciancio A; Battista C; Serio G; Liso V
Eur J Haematol; 2000 Aug; 65(2):114-7. PubMed ID: 10966171
[TBL] [Abstract][Full Text] [Related]
10. Familial occurrence of chronic lymphocytic leukaemia in Norway.
Tjønnfjord GE; Jønsson V; Ly BE; Johannesen TB
Tidsskr Nor Laegeforen; 2012 Oct; 132(18):2060-3. PubMed ID: 23038196
[TBL] [Abstract][Full Text] [Related]
11. Familial chronic lymphocytic leukemia: what does it mean to me?
Slager SL; Kay NE
Clin Lymphoma Myeloma; 2009; 9 Suppl 3(Suppl 3):S194-7. PubMed ID: 19778840
[TBL] [Abstract][Full Text] [Related]
12. Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden.
Landgren O; Kristinsson SY; Goldin LR; Caporaso NE; Blimark C; Mellqvist UH; Wahlin A; Bjorkholm M; Turesson I
Blood; 2009 Jul; 114(4):791-5. PubMed ID: 19182202
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders.
Brown JR; Neuberg D; Phillips K; Reynolds H; Silverstein J; Clark JC; Ash M; Thompson C; Fisher DC; Jacobsen E; LaCasce AS; Freedman AS
Br J Haematol; 2008 Nov; 143(3):361-8. PubMed ID: 18729853
[TBL] [Abstract][Full Text] [Related]
14. Familial study of chronic lymphocytic leukemia: aggregation of different malignant processes in families with individuals affected with chronic lymphocytic leukemia.
Nenova IS; Karnolski IN; Mateva NG; Sotirova KN
Folia Med (Plovdiv); 2006; 48(1):11-6. PubMed ID: 16918049
[TBL] [Abstract][Full Text] [Related]
15. Anticipation in familial chronic lymphocytic leukaemia.
Wiernik PH; Ashwin M; Hu XP; Paietta E; Brown K
Br J Haematol; 2001 May; 113(2):407-14. PubMed ID: 11380406
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of familial B-CLL in the National Cancer Institute Familial Registry.
Ishibe N; Sgambati MT; Fontaine L; Goldin LR; Jain N; Weissman N; Marti GE; Caporaso NE
Leuk Lymphoma; 2001 Jun; 42(1-2):99-108. PubMed ID: 11699227
[TBL] [Abstract][Full Text] [Related]
17. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
18. Anticipation in familial chronic lymphocytic leukaemia.
Yuille MR; Houlston RS; Catovsky D
Leukemia; 1998 Nov; 12(11):1696-8. PubMed ID: 9823943
[TBL] [Abstract][Full Text] [Related]
19. Familial chronic lymphocytic leukaemia: a survey and review of published studies.
Yuille MR; Matutes E; Marossy A; Hilditch B; Catovsky D; Houlston RS
Br J Haematol; 2000 Jun; 109(4):794-9. PubMed ID: 10929032
[TBL] [Abstract][Full Text] [Related]
20. Inherited predisposition to chronic lymphocytic leukemia.
Brown JR
Expert Rev Hematol; 2008 Oct; 1(1):51-61. PubMed ID: 19802369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
